Bone Cancer Applications
-
BSD-2000 - Deep Regional Hyperthermia System for Clinical
Randomized clinical trials (RCT’s) have been shown significant improvement in clinical outcome when hyperthermia was added to radiotherapy and/or chemotherapy. In 2004 experts in clinical hyperthermia held a consensus meeting (Kadota Fund International Forum 2004) about the evidence of the published clinical results of the RCT’s. Level 1 evidence was found for bladder cancer, breast cancer, cervical cancer, cancer of the esophagus, lymph nodes of head and neck tumors, rectum cancer, soft tissue ...
By Pyrexar based in Salt Lake City, UTAH (USA).
-
Zenalux Technology in Pre-clinical and Clinical Applications
Zenalux technology has been applied to the quantitative optical analysis of tissues in a number of published studies in both pre-clinical models and in patients. In the breast, the Zenalux technology has been proven to be sensitive to sources of intrinsic optical contrast, in particular, hemoglobin, beta carotene and scattering which effectively discriminate diseased from healthy tissues (see Published Papers.) ...
By Zenalux Biomedical, Inc. based in Durham, NORTH CAROLINA (USA).
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you